

Personalized GLP-1 medication plans designed to support appetite control and metabolic health.
Use code PGLP100 at checkout.


Most people don’t struggle with weight because they lack discipline. They struggle because their biology is working against them.
GLP-1 medications are designed to support the body’s natural appetite-regulating pathways, which may help some individuals experience greater consistency in appetite-related behaviors over time.
This isn’t about eating less. It’s about finally having the right support.

























Results may vary. Medication eligibility is determined by a licensed medical provider.
Ozempic® is a registered trademark of Novo Nordisk. Mounjaro® is a registered trademark of Eli Lilly. Compounded medications are not affiliated with or endorsed by Novo Nordisk or Eli Lilly, and are not reviewed by the FDA for safety or efficacy. Studies of Ozempic® and Mounjaro® showed up to 15% and 20% weight reduction, respectively, for some patients.
Answer a few quick questions so we can understand your goals and health history. This helps determine which treatment approach may be right for you.
A medical provider will look over your answers and determine if you’re a good fit—no appointment required.
Your prescription will be discreetly delivered right to your doorstep.
You’ll have access to Health Coaching, unlimited provider appointments, health courses, and access to our collaborative Shed Community.


Compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider's prescription. A prescription is only issued after a consultationwith a licensed provider who determines whether treatment is appropriate. Results may vary. Please refer to the Terms and Conditions for full details on the Shed weight-lossguarantee. In clinical trials of Wegovy® (2.4 mg), average weight loss was 15% and 20% when paired with diet and exercise.